<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Metabolic stress occurs at disease <z:hpo ids='HP_0003674'>onset</z:hpo> and causes altered <z:chebi fb="0" ids="5086">flavoprotein</z:chebi> redox activity that increases <z:chebi fb="0" ids="5086">flavoprotein</z:chebi> autofluorescence (FA) </plain></SENT>
<SENT sid="1" pm="."><plain>Using a new method to measure ocular FA, we studied women with subtle <z:e sem="disease" ids="C0042790" disease_type="Disease or Syndrome" abbrv="">visual dysfunction</z:e> due to <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>Each FA value was greater in the more affected eye of each woman with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, permitting identification of that eye in each case </plain></SENT>
<SENT sid="3" pm="."><plain><z:chebi fb="0" ids="5086">Flavoprotein</z:chebi> autofluorescence values averaged 60% greater in more affected eyes of women with <z:e sem="disease" ids="C0033845" disease_type="Disease or Syndrome" abbrv="">pseudotumor cerebri</z:e>, but not between eyes of healthy women (control subjects) </plain></SENT>
<SENT sid="4" pm="."><plain>These results demonstrate the clinical utility of FA and may permit early detection and monitoring of <z:chebi fb="46" ids="15035">retinal</z:chebi> and <z:e sem="disease" ids="C0029132" disease_type="Disease or Syndrome" abbrv="">optic nerve diseases</z:e> </plain></SENT>
</text></document>